Ann Gage, MD
Critical Care Medicine · Nashville, TNNPI 1124319595
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,000 of the $22,208 with a category attached, or 72.0%. 33 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 48.0% of the total. Reporting peaked in 2023 at $9,146 and has fallen 65.7% since, to $3,134 in 2025. Among critical care medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $145.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$11K
- Abiomed$7K
- Boston Scientific$703
- Abbott$431
- Pfizer$421
- Medtronic$388
- plus $3K from 27 others
Across 28 payments — averaging $4140.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$116K
- Eli Lilly$26
What the payments were for
- Speaking & faculty fees$16,00072%
- Grants$2221%
- Food & beverage$5,98627%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 18 | $10,667 |
| Abiomed | 17 | $7,043 |
| Boston Scientific | 16 | $703 |
| Abbott | 7 | $431 |
| Pfizer | 23 | $421 |
| Medtronic(2 entities) | 10 | $388 |
| Getinge USA Sales, LLC | 6 | $362 |
| Shockwave Medical, Inc | 4 | $297 |
| Novo Nordisk | 11 | $243 |
| Inari Medical, Inc. | 3 | $236 |
| Inquis Medical, Inc. | 3 | $227 |
| Edwards Lifesciences | 1 | $168 |
| Johnson & Johnson | 3 | $167 |
| Amgen | 4 | $162 |
| Teleflex LLC | 1 | $144 |
| Spectrawave, Inc | 3 | $93 |
| E.r. Squibb & Sons, L.L.C. | 3 | $81 |
| Angiodynamics, Inc. | 2 | $58 |
| Penumbra, Inc. | 3 | $42 |
| Novartis | 2 | $33 |
| Thrombolex, Inc. | 1 | $25 |
| Philips North America LLC | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Asahi Intecc USA, Inc. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| AstraZeneca | 1 | $19 |
| ZOLL Circulation Inc | 1 | $16 |
| Cardiovascular Systems Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Sanofi | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$10,500
- Impella$6,717
- PRESSUREWIRE$234
- Vascular Lithotripsy$231
- FLOWTRIEVER CATHETER, S$189
- CT THROMBECTOMY SYSTEM KIT$189
- Aventus$188
- HemoSphere$168
- Arrow$144
- Repatha$123
- XARELTO$120
- AVVIGO Guidance System$117
- OPTIS$114
- CoreValve Evolut$113
- CARDIOHELP$112
- Resolute$108
How this compares
$22,208 in reported general payments places this provider in the 95th percentile of 141 critical care medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 43 | $47,268 |
| EntrestoSacubitril/Valsartan | 28 | $41,633 |
| XareltoRivaroxaban | 13 | $18,107 |
| JardianceEmpagliflozin | 13 | $14,466 |
| Repatha SureclickEvolocumab | 11 | $9,886 |
| Atorvastatin Calcium | 120 | $1,754 |
| ClopidogrelClopidogrel Bisulfate | 75 | $920 |
| Nifedipine ErNifedipine | 37 | $897 |
| Metoprolol Succinate | 55 | $784 |
| Rosuvastatin Calcium | 68 | $750 |
| Losartan Potassium | 59 | $570 |
| Amiodarone Hcl | 20 | $553 |
| Ezetimibe | 17 | $418 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 11 | $417 |
| Carvedilol | 60 | $353 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $421 | $47,26843 claims |
| NovartisEntresto | $33 | $41,63328 claims |
| Johnson & JohnsonXarelto | $167 | $18,10713 claims |
| Boehringer IngelheimJardiance | $14 | $14,46613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 141 critical care medicine providers in Tennessee.
Other critical care medicine in Nashville
- Gordon BernardNashville$730K
- Todd RiceNashville$291K
- Jamie DeneauNashville$33K
- Lorraine WareNashville$18K
- Shelton HarrellNashville$16K
- Joseph SchlesingerNashville$15K
- Angelo CanonicoNashville$15K
- Erik HessNashville$14K
- Jonathan CaseyNashville$13K
- Eugene ElyNashville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.